Having problems with message search?
Besides the HDDW article you can also read the HDSA November 24, 2008 News Release on Xenazine Tablets Availabile in the U.S. here www.hdsa.org/xenazine where you'll also learn about how you can participate in a webcast to be hosted on Wednesday, December 3rd at 12 PM eastern time conducted by Ovation and HDSA to discuss Xenazine.
Click here http://www.hdsa.org/images/content/1/1/11586.pdf to view Ovation's invitation. If you can't read PDF documents the invitation reads:
Please Join Us for an Informational Web Cast and Q&A on Xenazine* (tetrabenazine) Tablets
When: Wednesday, December 3rd, 2008
Time: One Hour Live web cast with presentation and Q&A to begin at 12:00 p.m. ET
Time: One Hour Live web cast with presentation and Q&A to begin at 12:00 p.m. ET
Where: To view and listen** to the web cast, please visit http://media.xfactorcom.com/XenazineInformation/20081203/
The link will become live 5 minutes before the web cast begins
Password: Please enter password Xenazine2008 when prompted
Featured panelists include:
Dave Knocke, Executive Director of Marketing, Movement Disorders Business Unit, Ovation Pharmaceuticals
Barbara Boyle, National Executive Director & CEO, HDSA
Deb Lovecky, Director of Education Programs & Services, HDSA
Eric Pappert, MD, Neurologist
Barbara Boyle, National Executive Director & CEO, HDSA
Deb Lovecky, Director of Education Programs & Services, HDSA
Eric Pappert, MD, Neurologist
Please contact jlcarlson@... with questions
*Xenazine is a registered trademark of Cambridge Laboratories (Ireland) Limited.
** Limited phone lines are available for those who cannot access the web cast. Please contact (202) 621-2886 for information on how to access via phone.
Offline 
Send Email